Ewald Hannappel

Erlangen, BY 91058, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Thymosin β4 Is an Endogenous Iron Chelator and Molecular Switcher of Ferroptosis.

Thymosin β4 Is an Endogenous Iron Chelator and Molecular Switcher of Ferroptosis.

Journal: International journal of molecular sciences

Published: December 13, 2021

Thymosin fraction 5 re-evaluated after 35 years by high-resolution mass spectrometry.

Thymosin fraction 5 re-evaluated after 35 years by high-resolution mass spectrometry.

Journal: Expert opinion on biological therapy

Published: August 01, 2018

Loss of Glycine Transporter 1 Causes a Subtype of Glycine Encephalopathy with Arthrogryposis and Mildly Elevated Cerebrospinal Fluid Glycine.

Loss of Glycine Transporter 1 Causes a Subtype of Glycine Encephalopathy with Arthrogryposis and Mildly Elevated Cerebrospinal Fluid Glycine.

Journal: American journal of human genetics

Published: June 15, 2016

Functional consequence of fibulin-4 missense mutations associated with vascular and skeletal abnormalities and cutis laxa.

Functional consequence of fibulin-4 missense mutations associated with vascular and skeletal abnormalities and cutis laxa.

Journal: Matrix biology : journal of the International Society for Matrix Biology

Published: May 10, 2016

Identification of PDGF-BB binding to thymosin β4 by chemical cross-linking.

Identification of PDGF-BB binding to thymosin β4 by chemical cross-linking.

Journal: Expert opinion on biological therapy

Published: June 23, 2015

High-resolution mass spectrometry for thymosins detection and characterization.

High-resolution mass spectrometry for thymosins detection and characterization.

Journal: Expert opinion on biological therapy

Published: June 23, 2015

Peptide labeling with photoactivatable trifunctional cadaverine derivative and identification of interacting partners by biotin transfer.

Peptide labeling with photoactivatable trifunctional cadaverine derivative and identification of interacting partners by biotin transfer.

Journal: Analytical biochemistry

Published: January 22, 2014

MRTF-A controls vessel growth and maturation by increasing the expression of CCN1 and CCN2.

MRTF-A controls vessel growth and maturation by increasing the expression of CCN1 and CCN2.

Journal: Nature communications

Published: September 10, 2013

Thymosin β4 and tissue transglutaminase. Molecular characterization of cyclic thymosin β4.

Thymosin β4 and tissue transglutaminase. Molecular characterization of cyclic thymosin β4.

Journal: The protein journal

Published: August 27, 2013

High-resolution HPLC-ESI-MS characterization of the contact sites of the actin-thymosin β(4) complex by chemical and enzymatic cross-linking.

High-resolution HPLC-ESI-MS characterization of the contact sites of the actin-thymosin β(4) complex by chemical and enzymatic cross-linking.

Journal: Biochemistry

Published: August 09, 2013

In vivo imaging using fluorescent antibodies to tumor necrosis factor predicts therapeutic response in Crohn's disease.

In vivo imaging using fluorescent antibodies to tumor necrosis factor predicts therapeutic response in Crohn's disease.

Journal: Nature medicine

Published: April 12, 2013

Thymosin beta4 inhibits ADF/cofilin stimulated F-actin cycling and hela cell migration: reversal by active Arp2/3 complex.

Thymosin beta4 inhibits ADF/cofilin stimulated F-actin cycling and hela cell migration: reversal by active Arp2/3 complex.

Journal: Cytoskeleton (Hoboken, N.J.)

Published: November 29, 2012

Showing 1-12 of 17

Last Updated: 09/26/2026